Primary Job Title Senior Director, Preclinical Development Primary Organization MiroBio
Location Oxford, Oxfordshire, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Dr Boyd brings more than 20 years' experience in therapeutic antibody target discovery to OBT. He joined OBT from the MRC Toxicology Unit where as a senior investigator he identified novel lymphoma targets. He was previously head of proteome biology at Oxford Glycosciences where he led its oncology target discovery team. Dr Boyd holds a PhD
in Biochemistry from Sussex University and conducted post-doctoral research at the Royal Postgraduate Medical School and the Imperial Cancer Research Fund.
